Univfy Company
.png)
Univfy makes fertility care more affordable, successful, and predictable for women and couples navigating their family-building options. The Univfy AI Platform empowers individuals with personalized information and counseling to inform smarter spending and decision-making. Based on proprietary technology developed at Stanford University, Univfy uses a rigorous scientific process to develop and validate prediction models to support patient counseling at fertility centers in the US, Canada, and Europe. Their methods have been published in top, peer-reviewed research publications. Their personalized prognostics also enables fertility centers to offer value-based pricing to patients, capping financial risk and making multiple IVF treatments affordable. Univfy is commercialized in the US, Canada and EU, compliant with HIPAA, GDPR and PHIPA, CE-marked as medical device software in the EU, extensive global IP portfolio.
Technology:
Longevity FemTech
Industry:
Reproductive Health & Contraception
Headquarters:
Los Altos, California, United States
Founded Date:
06-11-2009
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
1
Total Funding:
$6,700,000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-02-06
Last Funding Type:
Series A
Register and Claim Ownership